nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—HTR7—sympathetic nervous system—metabolic syndrome X	0.0326	0.129	CbGeAlD
Eletriptan—Almotriptan—FMO3—metabolic syndrome X	0.0224	0.841	CrCbGaD
Eletriptan—HTR7—autonomic nervous system—metabolic syndrome X	0.0219	0.087	CbGeAlD
Eletriptan—HTR1B—artery—metabolic syndrome X	0.0161	0.064	CbGeAlD
Eletriptan—HTR1D—artery—metabolic syndrome X	0.0156	0.0619	CbGeAlD
Eletriptan—HTR1B—blood vessel—metabolic syndrome X	0.0125	0.0498	CbGeAlD
Eletriptan—HTR7—artery—metabolic syndrome X	0.0124	0.0493	CbGeAlD
Eletriptan—Body temperature decreased—Metformin—metabolic syndrome X	0.0123	0.0563	CcSEcCtD
Eletriptan—Hypothermia—Metformin—metabolic syndrome X	0.0123	0.0563	CcSEcCtD
Eletriptan—HTR1D—blood vessel—metabolic syndrome X	0.0121	0.0482	CbGeAlD
Eletriptan—HTR7—endothelium—metabolic syndrome X	0.0105	0.0417	CbGeAlD
Eletriptan—HTR7—blood vessel—metabolic syndrome X	0.00967	0.0384	CbGeAlD
Eletriptan—PTGS1—artery—metabolic syndrome X	0.00858	0.0341	CbGeAlD
Eletriptan—Chest discomfort—Metformin—metabolic syndrome X	0.00777	0.0356	CcSEcCtD
Eletriptan—Accidental injury—Metformin—metabolic syndrome X	0.00777	0.0356	CcSEcCtD
Eletriptan—PTGS1—endothelium—metabolic syndrome X	0.00724	0.0288	CbGeAlD
Eletriptan—PTGS1—blood vessel—metabolic syndrome X	0.00668	0.0266	CbGeAlD
Eletriptan—Neuropathy—Metformin—metabolic syndrome X	0.00645	0.0296	CcSEcCtD
Eletriptan—Ear pain—Metformin—metabolic syndrome X	0.00585	0.0268	CcSEcCtD
Eletriptan—CYP2A6—adipose tissue—metabolic syndrome X	0.00577	0.023	CbGeAlD
Eletriptan—HTR1B—cardiovascular system—metabolic syndrome X	0.00559	0.0222	CbGeAlD
Eletriptan—Injury—Metformin—metabolic syndrome X	0.00543	0.0249	CcSEcCtD
Eletriptan—HTR1D—cardiovascular system—metabolic syndrome X	0.00541	0.0215	CbGeAlD
Eletriptan—HTR1D—kidney—metabolic syndrome X	0.0053	0.0211	CbGeAlD
Eletriptan—HTR2B—cardiovascular system—metabolic syndrome X	0.00504	0.02	CbGeAlD
Eletriptan—Migraine—Metformin—metabolic syndrome X	0.00491	0.0225	CcSEcCtD
Eletriptan—Liver function test abnormal—Metformin—metabolic syndrome X	0.00461	0.0211	CcSEcCtD
Eletriptan—Abdominal pain upper—Metformin—metabolic syndrome X	0.00456	0.0209	CcSEcCtD
Eletriptan—HTR1A—cardiovascular system—metabolic syndrome X	0.00451	0.0179	CbGeAlD
Eletriptan—Cramp muscle—Metformin—metabolic syndrome X	0.00449	0.0206	CcSEcCtD
Eletriptan—HTR2B—adipose tissue—metabolic syndrome X	0.00444	0.0177	CbGeAlD
Eletriptan—Abdominal distension—Metformin—metabolic syndrome X	0.00434	0.0199	CcSEcCtD
Eletriptan—Influenza—Metformin—metabolic syndrome X	0.00431	0.0198	CcSEcCtD
Eletriptan—HTR7—cardiovascular system—metabolic syndrome X	0.00431	0.0171	CbGeAlD
Eletriptan—HTR7—kidney—metabolic syndrome X	0.00422	0.0168	CbGeAlD
Eletriptan—Angina pectoris—Metformin—metabolic syndrome X	0.0042	0.0193	CcSEcCtD
Eletriptan—Abdominal discomfort—Metformin—metabolic syndrome X	0.00413	0.019	CcSEcCtD
Eletriptan—CYP2A6—liver—metabolic syndrome X	0.00405	0.0161	CbGeAlD
Eletriptan—ABCB1—blood vessel—metabolic syndrome X	0.00395	0.0157	CbGeAlD
Eletriptan—Drowsiness—Metformin—metabolic syndrome X	0.00385	0.0176	CcSEcCtD
Eletriptan—Neuropathy peripheral—Metformin—metabolic syndrome X	0.00377	0.0173	CcSEcCtD
Eletriptan—Bradycardia—Metformin—metabolic syndrome X	0.00351	0.0161	CcSEcCtD
Eletriptan—Rhinitis—Metformin—metabolic syndrome X	0.00346	0.0159	CcSEcCtD
Eletriptan—Hypoaesthesia—Metformin—metabolic syndrome X	0.00343	0.0158	CcSEcCtD
Eletriptan—Oedema peripheral—Metformin—metabolic syndrome X	0.0034	0.0156	CcSEcCtD
Eletriptan—CYP2C9—cardiovascular system—metabolic syndrome X	0.00326	0.013	CbGeAlD
Eletriptan—Flushing—Metformin—metabolic syndrome X	0.0032	0.0147	CcSEcCtD
Eletriptan—Immune system disorder—Metformin—metabolic syndrome X	0.00312	0.0143	CcSEcCtD
Eletriptan—Chills—Metformin—metabolic syndrome X	0.0031	0.0142	CcSEcCtD
Eletriptan—PTGS1—cardiovascular system—metabolic syndrome X	0.00298	0.0118	CbGeAlD
Eletriptan—Flatulence—Metformin—metabolic syndrome X	0.00296	0.0136	CcSEcCtD
Eletriptan—Dysgeusia—Metformin—metabolic syndrome X	0.00294	0.0135	CcSEcCtD
Eletriptan—PTGS1—kidney—metabolic syndrome X	0.00292	0.0116	CbGeAlD
Eletriptan—Muscle spasms—Metformin—metabolic syndrome X	0.00289	0.0133	CcSEcCtD
Eletriptan—Tremor—Metformin—metabolic syndrome X	0.00282	0.0129	CcSEcCtD
Eletriptan—Ill-defined disorder—Metformin—metabolic syndrome X	0.00279	0.0128	CcSEcCtD
Eletriptan—Malaise—Metformin—metabolic syndrome X	0.00271	0.0124	CcSEcCtD
Eletriptan—Syncope—Metformin—metabolic syndrome X	0.00269	0.0124	CcSEcCtD
Eletriptan—HTR7—liver—metabolic syndrome X	0.00267	0.0106	CbGeAlD
Eletriptan—Palpitations—Metformin—metabolic syndrome X	0.00266	0.0122	CcSEcCtD
Eletriptan—Loss of consciousness—Metformin—metabolic syndrome X	0.00264	0.0121	CcSEcCtD
Eletriptan—PTGS1—adipose tissue—metabolic syndrome X	0.00263	0.0104	CbGeAlD
Eletriptan—CYP2C19—liver—metabolic syndrome X	0.0026	0.0104	CbGeAlD
Eletriptan—Hypertension—Metformin—metabolic syndrome X	0.00259	0.0119	CcSEcCtD
Eletriptan—Myalgia—Metformin—metabolic syndrome X	0.00256	0.0117	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00254	0.0117	CcSEcCtD
Eletriptan—Discomfort—Metformin—metabolic syndrome X	0.00253	0.0116	CcSEcCtD
Eletriptan—Oedema—Metformin—metabolic syndrome X	0.00245	0.0113	CcSEcCtD
Eletriptan—CYP3A4—kidney—metabolic syndrome X	0.00244	0.00968	CbGeAlD
Eletriptan—Mesoridazine—HTR2C—metabolic syndrome X	0.00242	0.0908	CrCbGaD
Eletriptan—Shock—Metformin—metabolic syndrome X	0.00241	0.0111	CcSEcCtD
Eletriptan—Nervous system disorder—Metformin—metabolic syndrome X	0.00241	0.011	CcSEcCtD
Eletriptan—CYP2D6—kidney—metabolic syndrome X	0.0024	0.00953	CbGeAlD
Eletriptan—Skin disorder—Metformin—metabolic syndrome X	0.00238	0.0109	CcSEcCtD
Eletriptan—Hyperhidrosis—Metformin—metabolic syndrome X	0.00237	0.0109	CcSEcCtD
Eletriptan—Anorexia—Metformin—metabolic syndrome X	0.00234	0.0107	CcSEcCtD
Eletriptan—Hypotension—Metformin—metabolic syndrome X	0.00229	0.0105	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00223	0.0103	CcSEcCtD
Eletriptan—Paraesthesia—Metformin—metabolic syndrome X	0.0022	0.0101	CcSEcCtD
Eletriptan—Dyspnoea—Metformin—metabolic syndrome X	0.00219	0.01	CcSEcCtD
Eletriptan—Somnolence—Metformin—metabolic syndrome X	0.00218	0.01	CcSEcCtD
Eletriptan—Dyspepsia—Metformin—metabolic syndrome X	0.00216	0.00991	CcSEcCtD
Eletriptan—Decreased appetite—Metformin—metabolic syndrome X	0.00213	0.00978	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00212	0.00972	CcSEcCtD
Eletriptan—Fatigue—Metformin—metabolic syndrome X	0.00211	0.0097	CcSEcCtD
Eletriptan—Constipation—Metformin—metabolic syndrome X	0.0021	0.00962	CcSEcCtD
Eletriptan—Feeling abnormal—Metformin—metabolic syndrome X	0.00202	0.00927	CcSEcCtD
Eletriptan—CYP2C9—liver—metabolic syndrome X	0.00202	0.00803	CbGeAlD
Eletriptan—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00201	0.0092	CcSEcCtD
Eletriptan—Urticaria—Metformin—metabolic syndrome X	0.00195	0.00894	CcSEcCtD
Eletriptan—Abdominal pain—Metformin—metabolic syndrome X	0.00194	0.0089	CcSEcCtD
Eletriptan—Thioridazine—HTR2C—metabolic syndrome X	0.00183	0.0685	CrCbGaD
Eletriptan—ABCB1—cardiovascular system—metabolic syndrome X	0.00176	0.00701	CbGeAlD
Eletriptan—Asthenia—Metformin—metabolic syndrome X	0.00176	0.00807	CcSEcCtD
Eletriptan—Pruritus—Metformin—metabolic syndrome X	0.00174	0.00796	CcSEcCtD
Eletriptan—ABCB1—kidney—metabolic syndrome X	0.00172	0.00685	CbGeAlD
Eletriptan—Diarrhoea—Metformin—metabolic syndrome X	0.00168	0.0077	CcSEcCtD
Eletriptan—Dizziness—Metformin—metabolic syndrome X	0.00162	0.00744	CcSEcCtD
Eletriptan—Vomiting—Metformin—metabolic syndrome X	0.00156	0.00715	CcSEcCtD
Eletriptan—ABCB1—adipose tissue—metabolic syndrome X	0.00155	0.00618	CbGeAlD
Eletriptan—Rash—Metformin—metabolic syndrome X	0.00155	0.0071	CcSEcCtD
Eletriptan—Dermatitis—Metformin—metabolic syndrome X	0.00154	0.00709	CcSEcCtD
Eletriptan—CYP3A4—liver—metabolic syndrome X	0.00154	0.00612	CbGeAlD
Eletriptan—Headache—Metformin—metabolic syndrome X	0.00154	0.00705	CcSEcCtD
Eletriptan—CYP2D6—liver—metabolic syndrome X	0.00151	0.00602	CbGeAlD
Eletriptan—Nausea—Metformin—metabolic syndrome X	0.00146	0.00668	CcSEcCtD
Eletriptan—ABCB1—liver—metabolic syndrome X	0.00109	0.00433	CbGeAlD
Eletriptan—ABCB1—Metabolism—NAMPT—metabolic syndrome X	7e-05	0.000139	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GCK—metabolic syndrome X	6.96e-05	0.000138	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—LIPC—metabolic syndrome X	6.96e-05	0.000138	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—AKT1—metabolic syndrome X	6.95e-05	0.000138	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—APOC3—metabolic syndrome X	6.91e-05	0.000137	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—AGT—metabolic syndrome X	6.89e-05	0.000137	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CETP—metabolic syndrome X	6.88e-05	0.000136	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—IL6—metabolic syndrome X	6.84e-05	0.000136	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—APOB—metabolic syndrome X	6.84e-05	0.000136	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—CD36—metabolic syndrome X	6.78e-05	0.000135	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—LEP—metabolic syndrome X	6.75e-05	0.000134	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—APOE—metabolic syndrome X	6.75e-05	0.000134	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CETP—metabolic syndrome X	6.71e-05	0.000133	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—FABP4—metabolic syndrome X	6.69e-05	0.000133	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—AKT1—metabolic syndrome X	6.69e-05	0.000133	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCL5—metabolic syndrome X	6.68e-05	0.000133	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—APOA1—metabolic syndrome X	6.67e-05	0.000132	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PPARA—metabolic syndrome X	6.66e-05	0.000132	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PLA2G4A—metabolic syndrome X	6.65e-05	0.000132	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	6.6e-05	0.000131	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IRS1—metabolic syndrome X	6.59e-05	0.000131	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	6.59e-05	0.000131	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—SCARB1—metabolic syndrome X	6.58e-05	0.000131	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—LIPC—metabolic syndrome X	6.56e-05	0.00013	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GCK—metabolic syndrome X	6.56e-05	0.00013	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IRS1—metabolic syndrome X	6.55e-05	0.00013	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—NAMPT—metabolic syndrome X	6.54e-05	0.00013	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—LPL—metabolic syndrome X	6.53e-05	0.00013	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—APOC3—metabolic syndrome X	6.51e-05	0.000129	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	6.5e-05	0.000129	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—LIPC—metabolic syndrome X	6.5e-05	0.000129	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GCK—metabolic syndrome X	6.5e-05	0.000129	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—APOC3—metabolic syndrome X	6.46e-05	0.000128	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—AGT—metabolic syndrome X	6.45e-05	0.000128	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—SCARB1—metabolic syndrome X	6.43e-05	0.000128	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	6.41e-05	0.000127	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IRS1—metabolic syndrome X	6.41e-05	0.000127	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—SREBF1—metabolic syndrome X	6.39e-05	0.000127	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	6.34e-05	0.000126	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CETP—metabolic syndrome X	6.32e-05	0.000126	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—APOE—metabolic syndrome X	6.32e-05	0.000125	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—AKT1—metabolic syndrome X	6.31e-05	0.000125	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—INS—metabolic syndrome X	6.31e-05	0.000125	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PPARA—metabolic syndrome X	6.3e-05	0.000125	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—INS—metabolic syndrome X	6.27e-05	0.000124	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CETP—metabolic syndrome X	6.27e-05	0.000124	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—APOA1—metabolic syndrome X	6.25e-05	0.000124	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—SREBF1—metabolic syndrome X	6.24e-05	0.000124	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—HMGCR—metabolic syndrome X	6.22e-05	0.000123	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GOT2—metabolic syndrome X	6.22e-05	0.000123	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CCL2—metabolic syndrome X	6.21e-05	0.000123	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CCL2—metabolic syndrome X	6.17e-05	0.000122	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—INS—metabolic syndrome X	6.14e-05	0.000122	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IGF1—metabolic syndrome X	6.1e-05	0.000121	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—AGT—metabolic syndrome X	6.1e-05	0.000121	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GOT2—metabolic syndrome X	6.07e-05	0.00012	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—HMGCR—metabolic syndrome X	6.07e-05	0.00012	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IGF1—metabolic syndrome X	6.06e-05	0.00012	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	6.06e-05	0.00012	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CCL2—metabolic syndrome X	6.04e-05	0.00012	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IRS1—metabolic syndrome X	6.02e-05	0.00012	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—SCARB1—metabolic syndrome X	6e-05	0.000119	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—APOE—metabolic syndrome X	5.98e-05	0.000119	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	5.95e-05	0.000118	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IGF1—metabolic syndrome X	5.94e-05	0.000118	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—APOA1—metabolic syndrome X	5.91e-05	0.000117	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	5.88e-05	0.000117	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	5.85e-05	0.000116	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—SREBF1—metabolic syndrome X	5.83e-05	0.000116	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SERPINE1—metabolic syndrome X	5.8e-05	0.000115	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—INS—metabolic syndrome X	5.77e-05	0.000114	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SERPINE1—metabolic syndrome X	5.76e-05	0.000114	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GOT2—metabolic syndrome X	5.72e-05	0.000114	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	5.72e-05	0.000114	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TGFB1—metabolic syndrome X	5.69e-05	0.000113	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCL2—metabolic syndrome X	5.67e-05	0.000113	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GOT2—metabolic syndrome X	5.67e-05	0.000113	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—HMGCR—metabolic syndrome X	5.67e-05	0.000113	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—G6PD—metabolic syndrome X	5.66e-05	0.000112	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SERPINE1—metabolic syndrome X	5.64e-05	0.000112	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	5.61e-05	0.000111	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AGT—metabolic syndrome X	5.59e-05	0.000111	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IGF1—metabolic syndrome X	5.58e-05	0.000111	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ABCA1—metabolic syndrome X	5.54e-05	0.00011	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—SLC2A4—metabolic syndrome X	5.54e-05	0.00011	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NOS3—metabolic syndrome X	5.53e-05	0.00011	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	5.52e-05	0.00011	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PPARG—metabolic syndrome X	5.51e-05	0.000109	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NOS3—metabolic syndrome X	5.5e-05	0.000109	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—APOE—metabolic syndrome X	5.47e-05	0.000109	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—LEP—metabolic syndrome X	5.47e-05	0.000109	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—APOA1—metabolic syndrome X	5.41e-05	0.000107	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	5.41e-05	0.000107	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ABCA1—metabolic syndrome X	5.41e-05	0.000107	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—INS—metabolic syndrome X	5.4e-05	0.000107	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GCKR—metabolic syndrome X	5.39e-05	0.000107	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—LPA—metabolic syndrome X	5.39e-05	0.000107	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NOS3—metabolic syndrome X	5.38e-05	0.000107	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GGT1—metabolic syndrome X	5.37e-05	0.000107	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GOT1—metabolic syndrome X	5.37e-05	0.000107	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TGFB1—metabolic syndrome X	5.36e-05	0.000106	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SERPINE1—metabolic syndrome X	5.3e-05	0.000105	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GGT1—metabolic syndrome X	5.24e-05	0.000104	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GOT1—metabolic syndrome X	5.24e-05	0.000104	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	5.22e-05	0.000104	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PPARG—metabolic syndrome X	5.21e-05	0.000103	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—APOA5—metabolic syndrome X	5.17e-05	0.000103	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	5.11e-05	0.000102	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—INS—metabolic syndrome X	5.11e-05	0.000101	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	5.1e-05	0.000101	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	5.1e-05	0.000101	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NOS3—metabolic syndrome X	5.06e-05	0.0001	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ABCA1—metabolic syndrome X	5.05e-05	0.0001	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—SLC2A4—metabolic syndrome X	5.05e-05	0.0001	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—ALB—metabolic syndrome X	4.95e-05	9.83e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GOT1—metabolic syndrome X	4.94e-05	9.8e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GGT1—metabolic syndrome X	4.94e-05	9.8e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GGT1—metabolic syndrome X	4.89e-05	9.71e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GOT1—metabolic syndrome X	4.89e-05	9.71e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IRS1—metabolic syndrome X	4.88e-05	9.69e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	4.81e-05	9.54e-05	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—AKT1—metabolic syndrome X	4.74e-05	9.41e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—NOS3—metabolic syndrome X	4.74e-05	9.4e-05	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—AKT1—metabolic syndrome X	4.71e-05	9.35e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—ALB—metabolic syndrome X	4.68e-05	9.29e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—INS—metabolic syndrome X	4.68e-05	9.28e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—IL6—metabolic syndrome X	4.67e-05	9.26e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—IL6—metabolic syndrome X	4.64e-05	9.2e-05	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—AKT1—metabolic syndrome X	4.61e-05	9.16e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCL2—metabolic syndrome X	4.6e-05	9.13e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—APOB—metabolic syndrome X	4.55e-05	9.04e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—IL6—metabolic syndrome X	4.54e-05	9.01e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IGF1—metabolic syndrome X	4.52e-05	8.98e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—NOS3—metabolic syndrome X	4.48e-05	8.89e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—APOB—metabolic syndrome X	4.45e-05	8.82e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PLA2G4A—metabolic syndrome X	4.43e-05	8.79e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—LPL—metabolic syndrome X	4.35e-05	8.63e-05	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—AKT1—metabolic syndrome X	4.33e-05	8.6e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PTGS2—metabolic syndrome X	4.33e-05	8.6e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	4.32e-05	8.58e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	4.31e-05	8.56e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—AKT1—metabolic syndrome X	4.31e-05	8.55e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	4.3e-05	8.53e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—LIPC—metabolic syndrome X	4.29e-05	8.51e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GCK—metabolic syndrome X	4.29e-05	8.51e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL6—metabolic syndrome X	4.28e-05	8.5e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—AKT1—metabolic syndrome X	4.28e-05	8.49e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL6—metabolic syndrome X	4.27e-05	8.47e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—APOC3—metabolic syndrome X	4.26e-05	8.45e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—LPL—metabolic syndrome X	4.24e-05	8.43e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—AKT1—metabolic syndrome X	4.19e-05	8.31e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—APOB—metabolic syndrome X	4.19e-05	8.31e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—APOB—metabolic syndrome X	4.15e-05	8.24e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CETP—metabolic syndrome X	4.13e-05	8.21e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CD36—metabolic syndrome X	4.13e-05	8.2e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	4.1e-05	8.14e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PTGS2—metabolic syndrome X	4.1e-05	8.13e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	4.08e-05	8.09e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL6—metabolic syndrome X	4.04e-05	8.02e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	4.04e-05	8.02e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CD36—metabolic syndrome X	4.03e-05	8.01e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—LPL—metabolic syndrome X	4e-05	7.94e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—LPL—metabolic syndrome X	3.97e-05	7.87e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	3.96e-05	7.86e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—AKT1—metabolic syndrome X	3.95e-05	7.84e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—AKT1—metabolic syndrome X	3.94e-05	7.81e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	3.84e-05	7.63e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PPARA—metabolic syndrome X	3.84e-05	7.62e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CD36—metabolic syndrome X	3.8e-05	7.54e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CD36—metabolic syndrome X	3.77e-05	7.48e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PPARA—metabolic syndrome X	3.75e-05	7.44e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	3.74e-05	7.42e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GOT2—metabolic syndrome X	3.74e-05	7.42e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—AKT1—metabolic syndrome X	3.73e-05	7.4e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—AGT—metabolic syndrome X	3.72e-05	7.38e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TGFB1—metabolic syndrome X	3.66e-05	7.26e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—APOE—metabolic syndrome X	3.65e-05	7.24e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TGFB1—metabolic syndrome X	3.64e-05	7.22e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—AGT—metabolic syndrome X	3.63e-05	7.21e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—APOA1—metabolic syndrome X	3.6e-05	7.15e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TGFB1—metabolic syndrome X	3.56e-05	7.07e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—APOE—metabolic syndrome X	3.56e-05	7.06e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PPARA—metabolic syndrome X	3.53e-05	7.01e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—APOA1—metabolic syndrome X	3.52e-05	6.98e-05	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	3.51e-05	6.97e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PPARA—metabolic syndrome X	3.5e-05	6.95e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	3.46e-05	6.87e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—AGT—metabolic syndrome X	3.42e-05	6.79e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—AGT—metabolic syndrome X	3.39e-05	6.73e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—APOE—metabolic syndrome X	3.35e-05	6.65e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TGFB1—metabolic syndrome X	3.34e-05	6.64e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	3.33e-05	6.61e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	3.33e-05	6.61e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—APOE—metabolic syndrome X	3.32e-05	6.6e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—APOA1—metabolic syndrome X	3.31e-05	6.58e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—APOA1—metabolic syndrome X	3.29e-05	6.52e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GGT1—metabolic syndrome X	3.23e-05	6.41e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GOT1—metabolic syndrome X	3.23e-05	6.41e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	3.19e-05	6.33e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PPARG—metabolic syndrome X	3.18e-05	6.3e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—INS—metabolic syndrome X	3.11e-05	6.18e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PPARG—metabolic syndrome X	3.1e-05	6.15e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—INS—metabolic syndrome X	3.04e-05	6.03e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PPARG—metabolic syndrome X	2.92e-05	5.8e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PPARG—metabolic syndrome X	2.9e-05	5.75e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—INS—metabolic syndrome X	2.86e-05	5.69e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ALB—metabolic syndrome X	2.86e-05	5.67e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—INS—metabolic syndrome X	2.84e-05	5.64e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ALB—metabolic syndrome X	2.79e-05	5.53e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL6—metabolic syndrome X	2.76e-05	5.47e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL6—metabolic syndrome X	2.74e-05	5.44e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—APOB—metabolic syndrome X	2.74e-05	5.44e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—NOS3—metabolic syndrome X	2.73e-05	5.42e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	2.71e-05	5.38e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL6—metabolic syndrome X	2.68e-05	5.32e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—NOS3—metabolic syndrome X	2.67e-05	5.29e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	2.66e-05	5.29e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ALB—metabolic syndrome X	2.63e-05	5.21e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—LPL—metabolic syndrome X	2.62e-05	5.19e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ALB—metabolic syndrome X	2.6e-05	5.17e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—AKT1—metabolic syndrome X	2.54e-05	5.05e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—AKT1—metabolic syndrome X	2.53e-05	5.02e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL6—metabolic syndrome X	2.52e-05	5e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—NOS3—metabolic syndrome X	2.51e-05	4.99e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	2.5e-05	4.96e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—NOS3—metabolic syndrome X	2.49e-05	4.94e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CD36—metabolic syndrome X	2.48e-05	4.93e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—AKT1—metabolic syndrome X	2.47e-05	4.91e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTGS2—metabolic syndrome X	2.44e-05	4.84e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—AKT1—metabolic syndrome X	2.32e-05	4.61e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PPARA—metabolic syndrome X	2.31e-05	4.59e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	2.3e-05	4.56e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	2.28e-05	4.52e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AGT—metabolic syndrome X	2.24e-05	4.44e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—APOE—metabolic syndrome X	2.19e-05	4.35e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—AKT1—metabolic syndrome X	2.18e-05	4.32e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—APOA1—metabolic syndrome X	2.17e-05	4.3e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—AKT1—metabolic syndrome X	2.06e-05	4.09e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	2.04e-05	4.06e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PPARG—metabolic syndrome X	1.91e-05	3.79e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	1.89e-05	3.74e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—INS—metabolic syndrome X	1.87e-05	3.72e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ALB—metabolic syndrome X	1.72e-05	3.41e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NOS3—metabolic syndrome X	1.64e-05	3.26e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	1.5e-05	2.98e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—AKT1—metabolic syndrome X	1.26e-05	2.49e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—AKT1—metabolic syndrome X	1.23e-05	2.43e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—AKT1—metabolic syndrome X	1.15e-05	2.29e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—AKT1—metabolic syndrome X	1.14e-05	2.27e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AKT1—metabolic syndrome X	7.55e-06	1.5e-05	CbGpPWpGaD
